Burjeel Holdings H1 Revenue Reaches AED2.79bn, Profit Nearly Doubles

Burjeel Holdings reported revenue of AED2.794 billion for the first half of 2026, marking a 4.4 percent increase compared with the same period last year. The Group also delivered strong earnings growth, with EBITDA excluding one-off items rising 24.6 percent to AED517 million.

Net profit excluding one-off items reached AED227 million, representing a 97.4 percent increase year-on-year. The results reflect continued growth across the Group's healthcare operations during the first six months of the year.

Patient Visits and Surgeries Continue to Increase

The Group recorded more than 3.7 million patient visits during the first half of 2026, an increase of 9.9 percent from the previous year. During the second quarter alone, patient visits grew by 12.4 percent, supported by rising demand for specialised healthcare services and the recovery of elective and high-acuity procedures.

Normalised revenue, excluding the impact of the Unified Procurement Programme (UPP), increased by 9.1 percent during the first half of the year and 8.6 percent in the second quarter.

Inpatient revenue grew 11.9 percent in the second quarter, while inpatient volumes increased 7.2 percent during the first half of 2026.

The Group also carried out 24,610 surgeries during the second quarter, reflecting a 7.4 percent increase compared with the same period last year.

Hospitals Business Remains the Largest Revenue Contributor

The Hospitals segment generated AED2.501 billion in revenue during the first half of 2026, up 5.4 percent year-on-year. This segment accounted for 89 percent of Burjeel Holdings' total revenue.

EBITDA excluding one-off items for the Hospitals segment increased 21.1 percent to AED562 million, while the EBITDA margin improved to 22.5 percent during the first half.

Meanwhile, the Medical Centres segment reported revenue of AED248 million, representing an 8.4 percent increase from the previous year. EBITDA excluding one-off items for this segment climbed 56.2 percent to AED28 million.

Cash Flow and Financial Position Improve

Burjeel Holdings also reported stronger cash generation during the first half of 2026.

Operating cash flow increased 76.8 percent to AED405 million, while free cash flow rose to AED354 million. Free cash flow conversion reached 72 percent during the reporting period.

Return on capital employed improved to 13.6 percent, compared with 12.4 percent during the corresponding period last year.

The Group maintained a stable net leverage ratio of 1.8x as of 30 June 2026.

Sukuk Issuance Supports Debt Refinancing

On 1 July 2026, Burjeel Holdings completed the issuance of US$500 million in Sukuk under its US$1.5 billion Sukuk Programme.

The proceeds from the Sukuk issuance were used to refinance existing debt. As of 31 July 2026, the Group's outstanding debt stood at AED1.915 billion, while AED672 million in committed undrawn credit facilities remained available.

Chairman and CEO Highlights Future Growth Strategy

Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings, said the Group will continue investing in advanced clinical care, research, medical education, digital transformation and AI-enabled healthcare.

He added that these investments are intended to create sustainable value, support future growth opportunities and help develop the next generation of healthcare services, backed by favourable market conditions, an experienced leadership team and a resilient operating model.